Michael Aberman is an angel investor based in New York, United States. The known portfolio counts 5 companies: Unnatural Products, Excision BioTherapeutics, Immunai, Rover Diagnostics and XenImmune Therapeutics.
Is Michael Aberman a fit for your startup?
Paste your website. AI checks the fit and scores every other investor too.
Investment focus
- Sector
- Healthcare
Contacts
Michael Aberman portfolio companies (5)
- Unnatural Products
- Excision BioTherapeutics
- Immunai
- Rover Diagnostics
- XenImmune Therapeutics
Investor Profile
Founders in the listed sector Healthcare, and focus areas Biotech, Drug Discovery and Pharmaceuticals will recognize the pattern in this portfolio.
Michael Aberman appears in Pre-Seed and Seed rounds across the known deals.
The portfolio and focus above give founders context on whether Michael Aberman matches their raise.
Similar investors
Showing 20 of 100
David Wiersma
angel investor
Tucson, United States
Chris Jackson
angel investor and operator angel
New York, United States
Uri Kedem
angel investor and operator angel
San Francisco, United States
Robert Stein
angel investor
New York, United States
Aaron Meyer
angel investor
New York, United States
Yoni Goldwasser
Co-Founder & Managing Director, Angel Investor
Berlin, Germany
Bernie Rudnick
Co-Founder
Newark, United States
Michael Jin
Managing Partner
Palo Alto, United States
Jeffrey Roh
angel investor and operator angel
Seattle, United States
Yury Kukushkin
angel investor
Boston, United States
Steven Altschuler
angel investor and operator angel
Philadelphia, United States
Jeff Huber
angel investor and operator angel
Seattle, United States
Michael Chambers
angel investor and operator angel
Fargo, United States
Andrew Sandford
angel investor
Boston, United States
Richard Ulevitch
angel investor
San Diego, United States
Michael Henry
Member
Berkeley, United States
Daniel Bradbury
angel investor and operator angel
San Diego, United States
Jeffrey Kaditz
angel investor
Alexander Saint-Amand
angel investor and operator angel
New York, United States
John Grossman
angel investor
Waltham, United States
Frequently asked questions
Who is Michael Aberman?
Michael Aberman is an angel investor based in New York, United States with 5 known investments on file, among them Unnatural Products, Excision BioTherapeutics and Immunai. The sections above list the sectors and stages attached to that record.
What does Michael Aberman invest in?
Listed sectors include Healthcare; listed focus areas include Biotech, Drug Discovery and Pharmaceuticals. Those tags come from the companies attached to this profile, so they read as a record of what has been backed rather than a stated preference for what comes next.
What stage does Michael Aberman invest at?
The known deals of Michael Aberman include Pre-Seed and Seed rounds. Stage is the strongest single filter when you build a target list: an investor with no record at your stage rarely starts with you.
How do I contact Michael Aberman?
An email address and a LinkedIn page are on file for Michael Aberman. The address stays masked on this page and is readable inside RaiseHunt after you create an account. The database holds no phone number for this profile.
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
Data: RaiseHunt investor dataset · Snapshot 5 September 2026 · How this data is built · Report a correction or request removal